Dr. Elizabeth Raetz MD Pediatric Hematologist-Oncologist

Dr. Elizabeth Raetz is a pediatric hematologist-oncologist in New York, New York. She is affiliated with multiple hospitals in the area, including Mount Sinai Hospital and NYU Langone Medical Center. She received her medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice for 22 years. She is one of 11 doctors at Mount Sinai Hospital and one of 7 at NYU Langone Medical Center who specialize in Pediatric Hematology-Oncology.

Are you Dr. Elizabeth Raetz? Claim your profile to make edits or add details. Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Pediatric Hematologist-Oncologist: General Pediatric Hematology & Oncology

Hospital Affiliation

Mount Sinai Hospital
Ranked #46 in Pediatrics: Cancer

NYU Langone Medical Center

Education & Medical Training

University of Wisconsin
Residency, Pediatrics, 1992 - 1995

University of Utah
Fellowship, Pediatric Hematology/Oncology, 1995 - 1998

University of Wisconsin School of Medicine and Public Health
Class of 1992

Certifications & Licensure

American Board of Family Medicine
Certified in Family Medicine

American Board of Family Medicine
Certified in Sports Medicine

IL State Medical License
Active through 2014

MO State Medical License
Active through 2015

Publications & Presentations

The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase III COG/PBMTC trial.
Pulsipher, M. A.,Langholz, B.,Wall, D. A.,Schultz, K. R.,Bunin, N.,Carroll, W. L.,Raetz, E.,Gardner, S.,Gastier-Foster, J. M.,Howrie, D.,Goyal, R. K.,Douglas, J. G.,Borowitz, M.,Barnes, Y.,Teachey, D. T.,Taylor, C.,Grupp, S. A.

A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL): A Report From the Therapeutic Advances in Childhood Leu
Raetz, E. A.,Morrison, D.,Romanos-Sirakis, E.,Gaynon, P.,Sposto, R.,Bhojwani, D.,Bostrom, B. C.,Brown, P.,Eckroth, E.,Cassar, J.,Malvar, J.,Buchbinder, A.,Carroll, W. L.

A Phase I Study of EZN-3042, a Novel Survivin Messenger Ribonucleic Acid (mRNA) Antagonist, Administered in Combination With Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL): A Report From the Therapeutic Advances in Childhood Leu
Raetz, E. A.,Morrison, D.,Romanos-Sirakis, E.,Gaynon, P.,Sposto, R.,Bhojwani, D.,Bostrom, B. C.,Brown, P.,Eckroth, E.,Cassar, J.,Malvar, J.,Buchbinder, A.,Carroll, W. L.

See all 50 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • AvMed Health Open Access
  • BCBS Blue Card PPO
  • BCBS Florida BlueCare HMO
  • BCBS Florida NetworkBlue
  • BCBS Florida Preferred Patient Care PPO
  • BCBS Illinois PPO
  • BCBS Minnesota Blue Cross Accord
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
  • WEA Trust Preferred Provider Plan - Trust Pref
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.